Popular on PrZen
- San Diego Patch Company sets up www.MauiStrong.help site to help raise money for the residents of Maui - 154
- Aquia Inc. Announces Support of Platform One's Iron Bank in an Effort to Centralize and Standardize Application Hardening Throughout the DoD - 145
- Esteemed Teacher and Author Sheds Light on Coping with Loss in Unusual Ways in New Novel, Hungry - 134
- Experienced Voices™ Podcast Series Hosts Leading Entrepreneurs on Secrets to Success, What Entrepreneurs Need to Know
- Integris Is New Company Name for TenCate Advanced Armour:
- Green Office Partner Ranked #1 on Crain's 100 Best Places to Work in Chicago
- Goddess Good Fridae's 'What A Feeling' Dropping During TIFF This Friday!
- Attorney Jake Cohen Joins Bisnar Chase's Personal Injury Litigation Team
- Television Personality and Speaker Angie Mizzell Pens New Memoir "Girl in the Spotlight" – Release Date October 3, 2023
- Panther Lending's Pre-Labor Day Webinar on Credit Card Debt Consolidation Attracts Over 5,000 Viewers
Similar on PrZen
- New data reveals 87% Australian adults have experienced a work-related musculoskeletal injury
- Higi Selects ThoroughCare to Assist in Managing Chronically Ill Patients
- New Study Finds Wide Disparities in Bicycle Safety Across U.S. Cities
- RelyMD Bolsters its Telehealth Platform with Mental Health Services via CuraLinc Partnership
- Live Good Inc. Celebrates Diversity and Unity: A Beacon of Progress in the Spirit of Crissy Field, Angel Island and the Buffalo Soldiers
- AMERICAST Provides PreCast Pads to Charge Stations
- Maryland Sedation Dentistry and Surgical Center Opens in Frederick Maryland
- The 2023 CGI Integrated Care Conference Explores Opportunities in Healthcare Improvement Discovered as a Result of the COVID-19 Pandemic
- Instant Gourmet Coffee With The Authentic Taste & Refreshing Smell Of Cafe De Olla, Infused With The Wonderful Health Benefits Of Superfoods
- Sparkling Logic Launching Generative AI-Powered Tool for Decision Management
Cardiovascular Clinical Sciences Names Dr. Jing Dai as New Head of Cardiac Core Lab
PrZen/33501859
Cardiovascular Imaging Expert to Lead Core Lab Services in Support of Clinical Trials
BOSTON - PrZen -- As cardiac imaging becomes more integrated in both clinical practice and research, Cardiovascular Clinical Sciences (CCS) announced today the appointment of Dr. Jing Dai as the new Director of Core Lab Operations.
Dr. Dai is a highly accomplished medical professional with an impressive academic background, having earned both an M.D. and Ph.D. from Peking University Health Science Center. With expertise in angiographic and CT imaging, she has played a vital role in numerous clinical studies at Beth Israel Deaconess Medical Center, evaluating a wide range of cardiovascular devices and technologies, including bare metal stents, drug-eluting stents, bioabsorbable scaffolds, drug-coated balloons, TAVR, and TMVR devices.
In addition to her clinical research experience, Dr. Dai has more than ten years of experience in the basic cardiovascular research field. Her research has made significant contributions to the understanding of the molecular mechanisms underlying atherosclerosis and dilated cardiomyopathy. Her dedication to advancing the field of cardiovascular research is reflected in her publications and her role as a reviewer for more than 20 prestigious journals.
"As the new Director of Core Lab Operations, Dr. Dai brings her wealth of knowledge and expertise to lead the lab's efforts to advance the understanding of cardiovascular disease and improve patient outcomes," says Dr. Lorraine Rusch, CEO of CCS. "We are confident in her leadership, and that her dedication and extensive experience will prove invaluable to the continued success of the lab."
CCS was founded in 1997 as a cardiovascular specific Contract Research Organization (CRO) by Dr. Marvin Konstam and Dr. James Udelson of Tufts Medical Center. It has established itself as the CRO of choice for pharmaceutical, biotechnology and medical device companies looking to conduct research to manage and treat cardiovascular diseases.
To learn more about CCS and services it provides the life sciences industry, please visit www.ccstrials.com
Dr. Dai is a highly accomplished medical professional with an impressive academic background, having earned both an M.D. and Ph.D. from Peking University Health Science Center. With expertise in angiographic and CT imaging, she has played a vital role in numerous clinical studies at Beth Israel Deaconess Medical Center, evaluating a wide range of cardiovascular devices and technologies, including bare metal stents, drug-eluting stents, bioabsorbable scaffolds, drug-coated balloons, TAVR, and TMVR devices.
In addition to her clinical research experience, Dr. Dai has more than ten years of experience in the basic cardiovascular research field. Her research has made significant contributions to the understanding of the molecular mechanisms underlying atherosclerosis and dilated cardiomyopathy. Her dedication to advancing the field of cardiovascular research is reflected in her publications and her role as a reviewer for more than 20 prestigious journals.
"As the new Director of Core Lab Operations, Dr. Dai brings her wealth of knowledge and expertise to lead the lab's efforts to advance the understanding of cardiovascular disease and improve patient outcomes," says Dr. Lorraine Rusch, CEO of CCS. "We are confident in her leadership, and that her dedication and extensive experience will prove invaluable to the continued success of the lab."
CCS was founded in 1997 as a cardiovascular specific Contract Research Organization (CRO) by Dr. Marvin Konstam and Dr. James Udelson of Tufts Medical Center. It has established itself as the CRO of choice for pharmaceutical, biotechnology and medical device companies looking to conduct research to manage and treat cardiovascular diseases.
To learn more about CCS and services it provides the life sciences industry, please visit www.ccstrials.com
Contact
Dr. Lorraine Rusch, President & CEO
Cardiovascular Clinical Sciences
lrusch@ccstrials.com
914-548-1690
Dr. Lorraine Rusch, President & CEO
Cardiovascular Clinical Sciences
lrusch@ccstrials.com
914-548-1690
Source: Cardiovascular Clinical Sciences
0 Comments
Latest on PrZen
- Vantiva Announces it has entered into an agreement with CommScope to acquire CommScope's Home Networks
- Car Accident Lawyer Tempe Accident Law Group
- Larry Hogan Joins Worldwide Speakers Group
- Pikmykid Hosts Webinar on Georgia School Safety Grant
- The Documented Culinary Journey of AI Influencer, Chef Jade
- American Garden Rose Selections™ Announces 2024 Winners
- Boutique Consulting Firm with Unique Project Leadership Offering is Now GSA Approved
- Robotics and Automation are Driving Demand for Upgraded Warehouse Management Systems concludes new report from the Mobile Robot Directory
- Doctors for Cannabis Regulation Rebrands as Doctors for Drug Policy Reform
- New data reveals 87% Australian adults have experienced a work-related musculoskeletal injury
- NEOM and Maysalward to strengthen young gaming talent with launch of NEOM Game Dev Challenge
- Jeezy, Sexyy Red, Plies, And $hyfromdatre Support The HBCU Community With A Special Concert For NC College Students In Winston-Salem, NC on Oct. 27th
- Global Luxury Value Exchange, Idoneus, Transitions to 100% IDON Transactions
- USA Green Card Celebrates the State Department's Historic Inclusion of the UK in the DV-2025 Green Card Lottery
- Do Grandparents Make Good Parents?
- Cleveland Broadband Selects Axiros' AXESS 5 ACS Software for Advanced Gigabit Internet Service
- Green Office Partner Ranks on the Inc. 5000 Annual List of the Fastest Growing Companies in America
- Office Calgary Inc, announces office expansion plans
- PFW Recap: CHOCHENG Spring/Summer 2024 Les Parapluies De CHOCHENG
- The New Trace One Ushers in a New Era for CPG and Retail Product Innovation